273 related articles for article (PubMed ID: 36172147)
21. Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.
Tang Z; Sun C; Yan Y; Niu Z; Li Y; Xu X; Zhang J; Wu Y; Li Y; Wang L; Hu C; Li Z; Jiang J; Ying H
J Mol Cell Biol; 2023 Feb; 14(9):. PubMed ID: 36352530
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
[TBL] [Abstract][Full Text] [Related]
23. Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.
Dubey PK; Patil M; Singh S; Dubey S; Ahuja P; Verma SK; Krishnamurthy P
Mol Cell Biochem; 2022 Jan; 477(1):129-141. PubMed ID: 34581943
[TBL] [Abstract][Full Text] [Related]
24. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of m6A Methyltransferase in the Hippocampus of
Lv Z; Xu T; Li R; Zheng D; Li Y; Li W; Yang Y; Hao Y
Front Neurosci; 2022; 16():739201. PubMed ID: 35386591
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in
Li H; Lin J; Cheng S; Chi J; Luo J; Tang Y; Zhao W; Shu Y; Liu X; Xu C
Front Cell Dev Biol; 2023; 11():1136096. PubMed ID: 37363723
[No Abstract] [Full Text] [Related]
27. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
[TBL] [Abstract][Full Text] [Related]
28. m
Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
[TBL] [Abstract][Full Text] [Related]
29. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
30. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
31. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of m6A modification in lipopolysaccharide-induced acute lung injury in mice.
Xu C; Song C; Wang W; Liu B; Li G; Fu T; Hao B; Li N; Geng Q
Mol Med; 2024 Jan; 30(1):14. PubMed ID: 38254010
[TBL] [Abstract][Full Text] [Related]
33. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
34. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
35. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
36. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of FTO inhibits excessive proliferation and promotes the apoptosis of human glomerular mesangial cells by alleviating FOXO6 m6A modification via YTHDF3-dependent mechanisms.
Zhuang X; Liu T; Wei L; Gao J
Front Pharmacol; 2023; 14():1260300. PubMed ID: 37822879
[No Abstract] [Full Text] [Related]
38. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
39. ALKBH5-mediated m
Chen Y; Zhou P; Deng Y; Cai X; Sun M; Sun Y; Wu D
Clin Transl Med; 2023 Feb; 13(2):e1198. PubMed ID: 36792369
[TBL] [Abstract][Full Text] [Related]
40. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]